NewsOK Local Stocks
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Local Stocks
Oragenics Inc (NY: OGEN)
0.4392 USD  -0.0153 (-3.37%)
Official Closing Price  /  Updated: 6:30 PM EDT, Aug 23, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 813,221
Open 0.4725
Bid (Size) 0.4543 (6)
Ask (Size) 0.4600 (13)
Prev. Close 0.4545
Today's Range 0.4251 - 0.4800
52wk Range 0.3500 - 3.740
Shares Outstanding 6,086,635
Dividend Yield N/A
Performance
YTD
-49.52%
-49.52%
1 Month
-6.17%
-6.17%
3 Month
-12.16%
-12.16%
6 Month
-52.77%
-52.77%
1 Year
+3.12%
+3.12%
Top News
More News
Investor Expectations to Drive Momentum within H&R Block, Aercap Holdings N.V, Oragenics, and Atomera — Discovering Underlying Factors of Influence
In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of H&R Block, Inc. (NYSE:HRB),... Read More
from GlobeNewswire News Releases
Oragenics, Inc. to Present Overview of Lantibiotics Pipeline at the Annual Military Health System Research Symposium
ORAGENICS, INC. TO PRESENT OVERVIEW OF LANTIBIOTICS PIPELINE AT THE ANNUAL MILITARY HEALTH SYSTEM RESEARCH SYMPOSIUM Read More
from Business Wire News Releases
More News
Read More
Oragenics, Inc. to Present Data on Its Peptide Synthesis Platform at the American Peptide Symposium
from Business Wire News Releases
Recent Peer-Reviewed Publication on Oragenics, Inc.’s Lantibiotic Antimicrobial Compound Identifies Alternative Mechanism of Action
from Business Wire News Releases
Oragenics, Inc. Provides Development Update of AG013 for Oral Mucositis
from Business Wire News Releases
Newly Published Preclinical Data on Oragenics, Inc.’s Lantibiotic Compound Demonstrates Tolerability and Compartmentalization to the GI Tract
from Business Wire News Releases
Oragenics, Inc. to Present at Spring Investor Summit on April 1, 2019
from Business Wire News Releases
Oragenics, Inc. Enters into Collaboration with Florida International University to Expand Its Pipeline of Lantibiotics
from Business Wire News Releases
Oragenics Announces Closing of $12.5 Million Underwritten Public Offering
from Business Wire News Releases
Oragenics Announces Pricing of $12.5 Million Underwritten Public Offering
from Business Wire News Releases
Organics Announces Proposed Underwritten Public Offering
from Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.